HEALTH OF WOMAN. 2019.2(138): 20–28; doi 10.15574/HW.2019.138.20

Dronova V. L. , Dronov O. I. , Mokryk O. M. , Rochina L. O. , Bakunets Yu. P.
SI «Institute of Pediatrics, Obstetrics and Gynecology named after academician O.M. Lukyanova NAMS of Ukraine», Kiev
Bogomolets National Medical University, Kiev
Kyiv City Clinical Hospital №10

The review article provides epidemiological data on the frequency, clinic, diagnosis and treatment of malignant neoplasms first discovered during this pregnancy as genital and extragenital localization. Surgical, specific or combined treatment is based on the principles of multidisciplinarity with the preservation of this pregnancy on the basis of Canadian and European gadgets (ESMO). The publication presents their own clinical cases.

Key words: malignant neoplasms, first discovered during pregnancy; genital and extraanitary forms of cancer; treatment of a pregnancy with its preservation.

REFERENCES

1. Gynecologic Cancers in Pregnancy: Guidelines of a Second International Consensus Meeting.

2. Han SN, Kesic VI, Van Calsteren K et al. (2013). Cancer in pregnancy: a survey of current clinical practice. Eur J Obstet Gynecol Reprod Biol. 167: 18–23. https://doi.org/10.1016/j.ejogrb.2012.10.026

3. Amant F, Van Calsteren K, Halaska MJ et al. (2009). Gynecologic cancers in pregnancy: guidelines of an international consensus meeting. Int J Gynecol Cancer. 19(1): S1–S12. https://doi.org/10.1111/IGC.0b013e3181a1d0ec

4. Kanal E, Barkovich AJ, Bell C et al. (2007). ACR guidance document for safe MR practices: 2007. AJR Am J Roentgenol. 188: 1447–1474. https://doi.org/10.2214/AJR.06.1616

5. Mazze RI, Kallen B. (1989). Reproductive outcome after anesthesia and operation during pregnancy: a registry study of 5405 cases. Am J Obstet Gynecol. 161: 1178–1185. https://doi.org/10.1016/0002-9378(89)90659-5

6. Bunyavejchevin S, Phupong V. (2013). Laparoscopic surgery for presumed benign ovarian tumor during pregnancy. Cochrane Database Syst Rev. 1: CD005459. https://doi.org/10.1002/14651858.CD005459.pub3

7. Telischak NA, Yeh BM, Joe BN et al. (2008). MRI of adnexal masses in pregnancy. AJR Am J Roentgenol. 191: 364–370. https://doi.org/10.2214/AJR.07.3509

8. Zhao XY, Huang HF, Lian LJ et al. (2006). Ovarian cancer in pregnancy: a clinicopathologic analysis of 22 cases and review of the literature. Int J Gynecol Cancer. 16: 8–15. https://doi.org/10.1111/j.1525-1438.2006.00422.x

9. Zagouri F, Sergentanis TN, Chrysikos D et al. (2012). Taxanes for ovarian cancer during pregnancy: a systematic review. Oncology 83: 234–238. https://doi.org/10.1159/000341351

10. Motegi M, Takakura S, Takano H et al. (2007). Adjuvant chemotherapy in a pregnant woman with endodermal sinus tumor of the ovary. Obstet Gynecol. 109: 537–540. https://doi.org/10.1097/01.AOG.0000245450.62758.47

11. Balleyguier C, Fournet C, Ben HW et al. (2013). Management of cervical cancer detected during pregnancy: role of magnetic resonance imaging. Clin Imaging. 37(1): 70–76. https://doi.org/10.1016/j.clinimag.2012.04.004

12. Schmeler KM, Frumovitz M, Ramirez PT. (2011). Conservative management of early stage cervical cancer: is there a role for less radical surgery? Gynecol Oncol. 120: 321–325. https://doi.org/10.1016/j.ygyno.2010.12.352

13. Morice P, Narducci F, Mathevet P et al. (2009). French recommendations on the management of invasive cervical cancer during pregnancy. Int J Gynecol Cancer. 19: 1638–1641. https://doi.org/10.1111/IGC.0b013e3181a83017

14. Sood AK, Sorosky JI, Mayr N et al. (1997). Radiotherapeutic management of cervical carcinoma that complicates pregnancy. Cancer. 80: 1073–1078. https://doi.org/10.1002/(SICI)1097-0142(19970915)80:6<1073::AID-CNCR9>3.0.CO;2-A

15. Rob L, Skapa P, Robova H. (2011). Fertility-sparing surgery in patients with cervical cancer. Lancet Oncol. 12: 192–200. https://doi.org/10.1016/S1470-2045(10)70084-X

16. Rydzewska L, Tierney J, Vale CL et al. (2012). Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer. Cochrane Database Syst Rev. 12: CD007406. https://doi.org/10.1002/14651858.CD007406.pub3

17. Zagouri F, Sergentanis TN, Chrysikos D et al. (2013). Platinum derivatives during pregnancy in cervical cancer: a systematic review and meta-analysis. Obstet Gynecol. 121: 337–343. https://doi.org/10.1097/AOG.0b013e31827c5822

18. Amant F, von Minckwitz G, Han SN et al. (2013). Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol. 31: 2532–2539. https://doi.org/10.1200/JCO.2012.45.6335

19. Evans SR, Sarani B, Bhanot P et al. (2012). Surgery in pregnancy. Curr Probl Surg. 49: 333–388. https://doi.org/10.1067/j.cpsurg.2012.02.003

20. Anderka M, Mitchell AA, Louik C et al. (2012). Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol. 94: 22–30. https://doi.org/10.1002/bdra.22865

21. Pasternak B, Svanstrom H, Hviid A. (2013). Ondansetron in pregnancy and risk of adverse fetal outcomes. N Engl J Med. 368: 814–823. https://doi.org/10.1056/NEJMoa1211035; PMid:23445092

22. Koren G, Florescu A, Costei AM et al. (2006). Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother. 40: 824–829. https://doi.org/10.1345/aph.1G428; PMid:16638921

23. Van Calsteren K, Verbesselt R, Ottevanger N et al. (2010). Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study. Acta Obstet Gynecol Scand. 89: 1338–1345. https://doi.org/10.3109/00016349.2010.512070; PMid:20846067

24. Hahn KM, Johnson PH, Gordon N et al. (2006). Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 107: 1219–1226. https://doi.org/10.1002/cncr.22081; PMid:16894524

25. Cardonick E, Bhat A, Gilmandyar D et al. (2012). Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature. Ann Oncol. 23: 3016–3023. https://doi.org/10.1093/annonc/mds170; PMid:22875836

26. Cardonick E, Iacobucci A. (2004). Use of chemotherapy during human pregnancy. Lancet Oncol. 5: 283–291. https://doi.org/10.1016/S1470-2045(04)01466-4

27. Cardonick E, Usmani A, Ghaffar S. (2010). Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry. Am J Clin Oncol. 33: 221–228. https://doi.org/10.1097/COC.0b013e3181a44ca9; PMid:19745695

28. Van Calsteren K, Heyns L, De Smet F et al. (2010). Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol. 28: 683–689. https://doi.org/10.1200/JCO.2009.23.2801; PMid:19841323

29. Amant F, Van Calsteren K, Halaska MJ et al. (2012). Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol. 13: 256–264. https://doi.org/10.1016/S1470-2045(11)70363-1

30. Morice P, Uzan C, Gouy S et al. (2012). Gynaecological cancers in pregnancy. Lancet. 379: 558–569. https://doi.org/10.1016/S0140-6736(11)60829-5

31. Pacheco S, Norero E, Canales C et al. (2016). The rare and challenging presentation of gastric cancer during pregnancy: a report of three cases. Jornal of Gastric Cancer 16(4): 271-276. https://doi.org/10.5230/jgc.2016.16.4.271; PMid:28053815 PMCid:PMC5206319

32. Norouzi A, Naeimi Tabei M, Tavassoli S et al. (2012). Hepatocellular carcinoma in pregnancy with unusual presentations. Middle East J Dig Dis 4: 228-31.

33. Dronov AI, Gorlach AI, Kryuchina EA. (2008). Kistoznyie neoplazmyi podzheludochnoy zhelezyi. Ukrainskiy zhurnal hirurgii 2: 15-26

34.Casey A Boyd, Jaime Benarroch-Gampel, Gokhan Kilik et al. (2012). Pancreatic neoplasms in pregnancy: diagnostic, complications and management. J.Gastrointest. surg. 16(5): 1064-1071. https://doi.org/10.1007/s11605-011-1797-y; PMid:22160782 PMCid:PMC3354643

35. Feng JF, Chen W, Guo Y, Liu J. 2015. Solid pseudopapillary tumor of the pancreas in a pregnant women. J. Surg. Rep. 74(4): 560-3.

36. Mac Donald F, Keough V, Huang W. (2014). Surgical therapy of a large pancreatic solid pseudopapillary neoplasm during pregnancy. BMJ Rep. 10:1136. https://doi.org/10.1136/bcr-2013-202259; PMid:24445849 PMCid:PMC3902659

37. Levy C, Pereira L, Dardarian T et al. (2004). Solid pseudopapillary pancreatic tumor in pregnancy. A case report. J. Reprod. Med. 49(1): 61-4.

38. Walker JL, Knight EL. (1986). Renal cell carcinoma in pregnancy. Cancer. 58(10): 2343-7. https://doi.org/10.1002/1097-0142(19861115)58:10<2343::AID-CNCR2820581031>3.0.CO;2-#

39. Gladman MA, MacDonald D. (2002). Renal cell carcinoma in pregnancy. J.R. Soc. Med.2 95(7): 378. https://doi.org/10.1177/014107680209500410; PMid:11934912 PMCid:PMC1279516

40. Alexander A, Harris RM, Grossman D et al. (2004). Vulvar melanoma: diffuse melanosis and metastasis to the placenta. J Am Acad Dermatol. 50: 293–298. https://doi.org/10.1016/j.jaad.2003.07.009; PMid:14726891